Keren Zhao

College of Engineering

2024 article

Chitosan-nanoclay embolic material for catheter-directed arterial embolization

Varghese, P. J. G., Zhao, K., Chen, P., & Hu, J. (2024, January 16). JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, Vol. 1.

By: P. Varghese n, K. Zhao n, P. Chen n & J. Hu n

author keywords: embolic agent; hydrogel; minimally invasive procedure; rheology; transcatheter injectability
TL;DR: A gel embolic agent comprising chitosan nanofibers and nanoclay with excellent catheter injectability and tunable mechanical properties for embolization is introduced with the potential for transcatheter embolization of vascular malformation and malignant/benign tumors. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: January 26, 2024

2024 journal article

Developing a transcatheter injectable nanoclay- alginate gel for minimally invasive procedures

JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 152.

By: K. Zhao n, P. Varghese n, P. Chen n & J. Hu n

author keywords: Minimally invasive procedure; Gel embolic agent; Shear -thinning; Transcatheter injectability
TL;DR: Overall, NC/alginate gel exhibited excellent stability and tunable injectability by optimizing the composition of each component, highlighting the gel's potential as a robust embolic agent for a wide range of minimally invasive procedures. (via Semantic Scholar)
UN Sustainable Development Goal Categories
2. Zero Hunger (OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: February 4, 2024

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.